Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-072189
Filing Date
2005-04-07
Accepted
2005-04-07 17:14:04
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 770192
2 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1989
3 CONSENT OF DELOITTE & TOUCHE LLP dex231.htm EX-23.1 1570
4 CERTIFICATION PURSUANT TO RULE 13A-14(A), PRESIDENT & CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 10298
5 CERTIFICATION PURSUANT TO RULE 13A-14(A), CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 10289
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION, PRESIDENT & CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 5038
7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION, CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 5026
  Complete submission text file 0001193125-05-072189.txt   806857
Mailing Address 189 WELLS ST STE 200 NEWTON MA 02459
Business Address 189 WELLS ST STE 200 NEWTON MA 02459 6175590033
PRO PHARMACEUTICALS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 05739815
SIC: 2834 Pharmaceutical Preparations